600866 logo

Star Lake BioscienceZhaoqing Guangdong XSSC:600866 Stock Report

Last Price

CN¥7.69

Market Cap

CN¥12.8b

7D

4.5%

1Y

20.2%

Updated

03 Jun, 2025

Data

Company Financials +

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong

XSSC:600866 Stock Report

Market Cap: CN¥12.8b

600866 Stock Overview

Engages in the manufacture and sale of pharmaceutical raw materials, and food and feed additives under the Star Lake and Yue Bao brand names in China and internationally. More details

600866 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth1/6
Past Performance5/6
Financial Health5/6
Dividends4/6

600866 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Competitors

Price History & Performance

Summary of share price highs, lows and changes for Star Lake BioscienceZhaoqing Guangdong
Historical stock prices
Current Share PriceCN¥7.69
52 Week HighCN¥7.94
52 Week LowCN¥4.76
Beta0.44
1 Month Change1.72%
3 Month Change20.53%
1 Year Change20.16%
3 Year Changen/a
5 Year Changen/a
Change since IPO25.86%

Recent News & Updates

Recent updates

Shareholder Returns

600866CN FoodCN Market
7D4.5%0.6%0.1%
1Y20.2%4.1%10.1%

Return vs Industry: 600866 exceeded the CN Food industry which returned 4.1% over the past year.

Return vs Market: 600866 exceeded the CN Market which returned 10.1% over the past year.

Price Volatility

Is 600866's price volatile compared to industry and market?
600866 volatility
600866 Average Weekly Movement6.1%
Food Industry Average Movement6.1%
Market Average Movement6.8%
10% most volatile stocks in CN Market10.0%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 600866 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 600866's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19649,293Ying Junwww.starlake.com.cn

Star Lake Bioscience Co., Inc Zhaoqing Guangdong engages in the manufacture and sale of pharmaceutical raw materials, and food and feed additives under the Star Lake and Yue Bao brand names in China and internationally. The company offers L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; guanosine that is used as an intermediate for food and pharmaceutical raw material; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroying Hepatitis B virus DNA; and L-threonine that is used in premixtures, and pig and poultry feed.

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Fundamentals Summary

How do Star Lake BioscienceZhaoqing Guangdong's earnings and revenue compare to its market cap?
600866 fundamental statistics
Market capCN¥12.78b
Earnings (TTM)CN¥1.17b
Revenue (TTM)CN¥17.17b
11.0x
P/E Ratio
0.7x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600866 income statement (TTM)
RevenueCN¥17.17b
Cost of RevenueCN¥13.97b
Gross ProfitCN¥3.21b
Other ExpensesCN¥2.04b
EarningsCN¥1.17b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.70
Gross Margin18.68%
Net Profit Margin6.79%
Debt/Equity Ratio46.5%

How did 600866 perform over the long term?

See historical performance and comparison

Dividends

4.9%
Current Dividend Yield
54%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/03 02:08
End of Day Share Price 2025/06/03 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhi Xue DiaoAvic Securities Co., Ltd
Zhe WangCitic Securities Co., Ltd.
Xiaohan SunHaitong International Research Limited
OSZAR »